Use of corticosteroids after hepatoportoenterostomy for bile drainage in infants with biliary atresia: the START randomized clinical trial
ContributorsBezerra, Jorge A; Spino, Cathie; Magee, John C; Shneider, Benjamin L; Rosenthal, Philip; Wang, Kasper S; Erlichman, Jessi; Haber, Barbara; Hertel, Paula M; Karpen, Saul J; Kerkar, Nanda; Loomes, Kathleen M; Molleston, Jean P; Murray, Karen F; Romero, Rene; Schwarz, Kathleen B; Shepherd, Ross; Suchy, Frederick J; Turmelle, Yumirle P; Whitington, Peter F; Moore, Jeffrey; Sherker, Averell H; Robuck, Patricia R; Sokol, Ronald J; Childhood Liver Disease Research and Education Network (ChiLDREN).
CollaboratorsMclin, Valérie Anne
Published inJAMA, vol. 311, no. 17, p. 1750-1759
Publication date2014
Abstract
Keywords
- Administration, Oral
- Adrenal Cortex Hormones/administration & dosage/adverse effects
- Biliary Atresia/drug therapy/surgery
- Bilirubin/blood
- Double-Blind Method
- Drainage/methods
- Female
- Humans
- Infant
- Infusions, Intravenous
- Male
- Methylprednisolone/administration & dosage/adverse effects
- Portoenterostomy, Hepatic
- Prednisolone/administration & dosage/adverse effects
- Survival Analysis
- Treatment Outcome
Research group
Citation (ISO format)
BEZERRA, Jorge A et al. Use of corticosteroids after hepatoportoenterostomy for bile drainage in infants with biliary atresia: the START randomized clinical trial. In: JAMA, 2014, vol. 311, n° 17, p. 1750–1759. doi: 10.1001/jama.2014.2623
Main files (1)
Article (Published version)
Identifiers
- PID : unige:55234
- DOI : 10.1001/jama.2014.2623
- PMID : 24794368
ISSN of the journal0098-7484
